MRP3/ABCC3 Antibody [L20F24]

Catalog No.: F4101

    Application: Reactivity:
    • Lane 1: Human liver, Lane 2: Mouse liver, Lane 3: Rat liver
    1/

    当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

    代表番号: 045-509-1970|電子メール:sales@selleck.co.jp

    キーポイント

    WB
    SDS-PAGE の分離ゲルの推奨濃度:5%
    60秒以上の露光(暴露)を推奨します。

    使用情報

    Dilution
    1:1000
    1:50
    Application
    WB, IP
    Source
    Rabbit Monoclonal Antibody
    Reactivity
    Human, Mouse, Rat
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    160-220 kDa
    ポジティブコントロール Human liver; Mouse liver; Rat liver; C2C12 cells; mIMCD-3 cells
    ネガティブコントロール

    プロトコール

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Add protein loading buffer to the 20 μL sample, and keep it on ice for immediate use; or determine the optimal denaturation conditions by boiling the sample at a temperature gradient (e.g., 37°C, 50°C, 70°C, 90°C, and 100°C). Cool the sample on ice and centrifuge for 5 min.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system. (Exposure time of at least 60s is recommended)

    Datasheet & SDS

    生物学的記述

    Specificity
    MRP3/ABCC3 Antibody [L20F24] detects endogenous levels of total MRP3/ABCC3 protein.
    タンパク質の局在
    細胞膜、細胞内膜系
    Uniprot ID
    O15438
    Clone
    L20F24
    Synonym(s)
    ATP-binding cassette sub-family C member 3; Canalicular multispecific organic anion transporter 2; Multi-specific organic anion transporter D (MOAT-D); Multidrug resistance-associated protein 3; ABCC3; CMOAT2; MLP2; MRP3
    Background
    MRP3 (ABCC3) is a membrane bound ATP binding cassette (ABC) transporter of the multidrug resistance associated protein subfamily that functions as a key efflux pump for a broad spectrum of organic anions and conjugated xenobiotics across polarized epithelia. It localizes predominantly to the basolateral plasma membrane of hepatocytes, enterocytes, renal tubular cells, and adrenal epithelia, where it couples ATP hydrolysis to the outward transport of compounds such as monoanionic bile acids, glucuronidated and sulfated metabolites, and chemotherapeutic agents including etoposide and paclitaxel, thereby preventing intracellular accumulation and contributing to cellular detoxification and barrier function. In the liver, MRP3 mediated basolateral efflux of bile acid conjugates and drug metabolites into the sinusoidal blood supports cholehepatic and enterohepatic circulation, and its induction during cholestasis serves as an adaptive mechanism to relieve biliary obstruction related toxicity by shunting bile anions into the systemic circulation for renal excretion, while in the intestine MRP3 modulates the net absorption and systemic exposure of orally administered drugs and endogenous anions. MRP3 expression is transcriptionally regulated by nuclear receptors such as PXR, CAR, and FXR, as well as by pro inflammatory and cholestatic signaling cascades, and its upregulation in Dubin Johnson syndrome, where MRP2 is defective, underscores a compensatory role in maintaining bile salt and conjugate efflux in the absence of functional canalicular export. Elevated MRP3 levels are observed in hepatocellular carcinomas, ovarian malignancies, and acute leukemias, where it contributes to chemoresistance by reducing intracellular drug concentrations and is associated with poorer prognosis in adult acute lymphoblastic and myeloid leukemias.
    References

    技術サポート

    ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

    Handling Instructions

    他に質問がある場合は、お気軽にお問い合わせください。

    * 必須

    大学・企業名を記入してください
    名前を記入してください
    電子メール・アドレスを記入してください 有効なメールアドレスを入力してください
    お問い合わせ内容をご入力ください